Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test

被引:48
|
作者
Rosenfield, Robert L. [1 ]
Mortensen, Monica
Wroblewski, Kristen [2 ]
Littlejohn, Elizabeth
Ehrmann, David A.
机构
[1] Univ Chicago, Pritzker Sch Med, Sect Adult & Pediat Endocrinol, Dept Pediat & Med,Med Ctr, Chicago, IL 60637 USA
[2] Univ Chicago, Pritzker Sch Med, Dept Hlth Studies, Chicago, IL 60637 USA
关键词
glucose intolerance; functional adrenal hyperandrogenism; functional ovarian hyperandrogenism; obesity; LUTEINIZING-HORMONE; INSULIN-SECRETION; FREE TESTOSTERONE; PRODUCTION-RATES; NORMAL WOMEN; HYPERANDROGENISM; HIRSUTISM; OBESITY; DEHYDROEPIANDROSTERONE; STEROIDOGENESIS;
D O I
10.1093/humrep/der291
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Polycystic ovary syndrome (PCOS) patients typically have 17-hydroxyprogesterone (17OHP) hyperresponsiveness to GnRH agonist (GnRHa) (PCOS-T). The objective of this study was to determine the source of androgen excess in the one-third of PCOS patients who atypically lack this type of ovarian dysfunction (PCOS-A). METHODS: Aged-matched PCOS-T (n = 40), PCOS-A (n = 20) and controls (n 39) were studied prospectively in a General Clinical Research Center. Short (4 h) and long (4-7 day) dexamethasone androgen-suppression tests (SDAST and LDAST, respectively) were compared in subsets of subjects. Responses to SDAST and low-dose adrenocorticotropic hormone (ACTH) were then evaluated in all. RESULTS: Testosterone post-SDAST correlated significantly with testosterone post-LDAST and 17OHP post-GnRHa (r = 0.671-0.672), indicating that all detect related aspects of ovarian dysfunction. An elevated dehydroepiandrosterone peak in response to ACTH, which defined functional adrenal hyperandrogenism, was similarly prevalent in PCOS-T (27.5%) and PCOS-A (30%) and correlated significantly with baseline dehydroepiandrosterone sulfate (DHEAS) (r = 0.708). Functional ovarian hyperandrogenism was detected by subnormal testosterone suppression by SDAST in most (92.5%) PCOS-T, but significantly fewer PCOS-A (60%, P < 0.01). Glucose intolerance was absent in PCOS-A, but present in 30% of PCOS-T (P < 0.001). Most of the PCOS-A cases with normal testosterone suppression in response to SDAST (5/8) lacked evidence of adrenal hyperandrogenism and were obese. CONCLUSIONS: Functional ovarian hyperandrogenism was not demonstrable by SDAST in 40% of PCOS-A. Most of these cases had no evidence of adrenal hyperandrogenism. Obesity may account for most hyperandrogenemic anovulation that lacks a glandular source of excess androgen, and the SDAST seems useful in making this distinction.
引用
收藏
页码:3138 / 3146
页数:9
相关论文
共 24 条
  • [11] SERUM CORTISOL CONCENTRATIONS DURING LOW-DOSE DEXAMETHASONE SUPPRESSION TEST TO SCREEN FOR CUSHINGS-SYNDROME
    KENNEDY, L
    ATKINSON, AB
    JOHNSTON, H
    SHERIDAN, B
    HADDEN, DR
    BRITISH MEDICAL JOURNAL, 1984, 289 (6453): : 1188 - 1191
  • [12] SERUM CORTISOL CONCENTRATIONS DURING LOW-DOSE DEXAMETHASONE SUPPRESSION TEST TO SCREEN FOR CUSHINGS-SYNDROME
    MATTINGLY, D
    TYLER, C
    BRITISH MEDICAL JOURNAL, 1985, 290 (6462): : 158 - 158
  • [13] SUPPRESSION OF BASAL PLASMA-CORTISOL AND ADRENAL ANDROGEN CONCENTRATIONS, BUT NOT OF ACTH AND CORTISOL RESPONSES TO HCRH BY LOW-DOSE DEXAMETHASONE IN RHESUS-MONKEYS
    SCHURMEYER, TH
    GALLUCCI, BT
    TOMAI, TP
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1988, 30 (1-6): : 435 - 437
  • [14] LOW-DOSE KETOCONAZOLE ATTENUATES SERUM ANDROGEN LEVELS IN PATIENTS WITH POLYCYSTIC-OVARY-SYNDROME AND INHIBITS OVARIAN STEROIDOGENESIS IN-VITRO
    GAL, M
    ORLY, J
    BARR, I
    ALGUR, N
    BOLDES, R
    DIAMANT, YZ
    FERTILITY AND STERILITY, 1994, 61 (05) : 823 - 832
  • [15] Discriminatory value of low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome
    Zarkovic, M
    Ciric, J
    Beleslin, B
    Penezic, Z
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03): : 1486 - 1486
  • [16] Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome
    Isidori, AM
    Kaltsas, GA
    Mohammed, S
    Morris, DG
    Jenkins, P
    Chew, SL
    Monson, JP
    Besser, GM
    Grossman, AB
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11): : 5299 - 5306
  • [17] INCREASE IN ANDROGEN-ESTROGEN RATIO SPECIFICALLY DURING LOW-DOSE FOLLICLE-STIMULATING-HORMONE THERAPY FOR POLYCYSTIC-OVARY-SYNDROME
    BRZYSKI, RG
    GROW, DR
    SIMS, JA
    SELTMAN, HJ
    FERTILITY AND STERILITY, 1995, 64 (04) : 693 - 697
  • [18] Low Diagnostic Utility of Overnight High-Dose Dexamethasone Suppression Test in ACTH-Dependent Cushing's Syndrome
    Kumar, Anand
    Kanwar, Jayabhanu
    Bharti, Niharika
    Agrawal, Vinita
    Bhatia, Eesh
    Yadav, Subhash Chandra
    ENDOCRINE PRACTICE, 2021, 27 (07) : 723 - 727
  • [19] The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome
    Tsagarakis, S
    Kokkoris, P
    Roboti, C
    Malagari, C
    Kaskarelis, J
    Vlassopoulou, V
    Alevizaki, C
    Thalassinos, N
    CLINICAL ENDOCRINOLOGY, 1998, 48 (05) : 627 - 633
  • [20] The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome
    Reimondo, Giuseppe
    Bovio, Silvia
    Allasino, Barbara
    De Francia, Silvia
    Zaggia, Barbara
    Micossi, Ilaria
    Termine, Angela
    De Martino, Francesca
    Paccotti, Piero
    Di Carlo, Francesco
    Angeli, Alberto
    Terzolo, Massimo
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 159 (05) : 569 - 576